Prot #XPORT-GBM-029: A Phase 1/2 Study of Selinexor in Combination with Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma

Project: Research project

Status	Active
Effective start/end date	11/3/20 → 11/3/23

Project Details